GSK’s Arexvy Is First RSV Vaccine Approved By FDA, But A Second Is Poised To Follow

 
• By Jessica Merrill
finish line
GSK got its RSV vaccine across the FDA finish line first • Source: Shutterstock

More from New Products

More from Scrip